lobbying_activities: 2467949

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2467949	1348a79c-aa7b-4bee-9edc-6776bdee273b	Q2	TRAVERE THERAPEUTICS	401104190	TRAVERE THERAPEUTICS	2020	second_quarter	CPT	H.R. 990 and S. 344, the Hatch-Waxman Integrity Act; S. 1416, Affordable Prescriptions for Patients Act of 2019: H.R. 3991, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019; H.R. 4398, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; Senate amendment to H.R. 2486	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		150000	0	0	2020-07-16T11:28:25.487000-04:00